Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pavan Reddy

Showing results (181-190 of 228) with videos related to

Pageof 23
Sort By:
The Journal of Clinical Investigation|March 5, 2013
Blockade of individual Notch ligands and receptors controls graft-versus-host diseaseIvy T Tran, Ashley R Sandy, Alexis J Carulli, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 4, 2012
TNF-inhibition with etanercept for graft-versus-host disease prevention in high-risk HCT: lower TNFR1 levels correlate with better outcomesSung W Choi, Patrick Stiff, Kenneth Cooke, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|April 18, 2024
From chest pain to coronary functional testing: Clinical and economic impact of coronary microvascular dysfunctionIlan Merdler, Ryan Wallace, Andrew P Hill, et al.
Annals of Hematology|March 19, 2015
Allogeneic transplantation with myeloablative FluBu4 conditioning improves survival compared to reduced intensity FluBu2 conditioning for acute myeloid leukemia in remissionJohn M Magenau, Thomas Braun, Pavan Reddy, et al.
Blood|August 16, 2011
Clofarabine and busulfan conditioning facilitates engraftment and provides significant antitumor activity in nonremission hematologic malignanciesJohn Magenau, Hiromi Tobai, Attaphol Pawarode, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|September 4, 2025
Decision-making in valve reintervention: Redo-Transcatheter aortic valve replacement vs. explant surgeryLior Lupu, Pavan Reddy, Dan Haberman, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 4, 2014
Etanercept plus topical corticosteroids as initial therapy for grade one acute graft-versus-host disease after allogeneic hematopoietic cell transplantationErin Gatza, Thomas Braun, John E Levine, et al.
Cell Stem Cell|September 4, 2024
Inflammation-induced epigenetic imprinting regulates intestinal stem cellsDongchang Zhao, Visweswaran Ravikumar, Tyler J Leach, et al.
Blood|December 18, 2024
Oral inflammation and microbiome dysbiosis exacerbate chronic graft-versus-host diseaseYui Kambara, Hideaki Fujiwara, Akira Yamamoto, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|July 16, 2024
High-risk percutaneous coronary intervention with or without mechanical circulatory support: Will Impella show superiority in the PROTECT IV randomized trial?Kalyan R Chitturi, Cheng Zhang, Waiel Abusnina, et al.
Pageof 23

Showing results (181-190 of 228) with videos related to

Sort By:
Pageof 23
The Journal of Clinical Investigation|March 5, 2013
Blockade of individual Notch ligands and receptors controls graft-versus-host diseaseIvy T Tran, Ashley R Sandy, Alexis J Carulli, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 4, 2012
TNF-inhibition with etanercept for graft-versus-host disease prevention in high-risk HCT: lower TNFR1 levels correlate with better outcomesSung W Choi, Patrick Stiff, Kenneth Cooke, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|April 18, 2024
From chest pain to coronary functional testing: Clinical and economic impact of coronary microvascular dysfunctionIlan Merdler, Ryan Wallace, Andrew P Hill, et al.
Annals of Hematology|March 19, 2015
Allogeneic transplantation with myeloablative FluBu4 conditioning improves survival compared to reduced intensity FluBu2 conditioning for acute myeloid leukemia in remissionJohn M Magenau, Thomas Braun, Pavan Reddy, et al.
Blood|August 16, 2011
Clofarabine and busulfan conditioning facilitates engraftment and provides significant antitumor activity in nonremission hematologic malignanciesJohn Magenau, Hiromi Tobai, Attaphol Pawarode, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|September 4, 2025
Decision-making in valve reintervention: Redo-Transcatheter aortic valve replacement vs. explant surgeryLior Lupu, Pavan Reddy, Dan Haberman, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 4, 2014
Etanercept plus topical corticosteroids as initial therapy for grade one acute graft-versus-host disease after allogeneic hematopoietic cell transplantationErin Gatza, Thomas Braun, John E Levine, et al.
Cell Stem Cell|September 4, 2024
Inflammation-induced epigenetic imprinting regulates intestinal stem cellsDongchang Zhao, Visweswaran Ravikumar, Tyler J Leach, et al.
Blood|December 18, 2024
Oral inflammation and microbiome dysbiosis exacerbate chronic graft-versus-host diseaseYui Kambara, Hideaki Fujiwara, Akira Yamamoto, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|July 16, 2024
High-risk percutaneous coronary intervention with or without mechanical circulatory support: Will Impella show superiority in the PROTECT IV randomized trial?Kalyan R Chitturi, Cheng Zhang, Waiel Abusnina, et al.
Pageof 23